You are here
Appendix 3. Plasma and Recombinant Products Supplied Under Contract in 2018-19
TABLE 5.2 Plasma and recombinant products supplied under contract 2018-19
| Product Type | Name | Presentation | Supplier | Price |
|---|---|---|---|---|
| Albumin (plasma derived - domestic) | Albumex | 20% 10ml | CSL Behring (Australia) Pty Ltd | $15.501 |
| 20% 100ml | $67.621 | |||
| 4% 50ml | $15.501 | |||
| 4% 500ml | $67.621 | |||
| Factor VIIa (recombinant - imported) |
NovoSeven | 1mg | Novo Nordisk Pharmaceuticals Pty Ltd | $1,333.77 |
| 2mg | $2,667.51 | |||
| 5mg | $6,668.78 | |||
| 8mg | $10,670.07 | |||
| Factor VIII Anti-Inhibitor (plasma derived - imported) | FEIBA | 500 IU | Shire Australia Pty Limited | $1,200.00 |
| 1000 IU | $2,400.00 | |||
| 2500IU | $6,000.00 | |||
| Factor VIII (plasma derived - domestic) | Biostate | 250 IU | CSL Behring (Australia) Pty Ltd | $218.141 |
| 500 IU | $436.291 | |||
| 1000 IU | $872.571 | |||
| Factor VIII (recombinant - imported) |
Advate | 250 IU | Shire Australia Pty Limited | $75.00 |
| 500 IU | $150.00 | |||
| 1000 IU | $300.00 | |||
| 1500 IU | $450.00 | |||
| 2000 IU | $600.00 | |||
| 3000 IU | $900.00 | |||
| Factor VIII (recombinant - imported) |
Eloctate | 250 IU | Sanofi-aventis Australia Pty Ltd | * |
| 500 IU | * | |||
| 1000 IU | * | |||
| 2000 IU | * | |||
| 3000 IU | * | |||
| Factor IX (recombinant - imported) |
Alprolix | 250 IU | Sanofi-aventis Australia Pty Ltd | * |
| 500 IU | * | |||
| 1000 IU | * | |||
| 2000 IU | * | |||
| 3000 IU | * | |||
| Factor VIII (recombinant - imported) |
Xyntha | 250 IU | Pfizer Australia Pty Ltd | $90.00 |
| 500 IU | $180.00 | |||
| 1000 IU | $360.00 | |||
| 2000 IU | $720.00 | |||
| 3000 IU | $1,080.00 | |||
| Factor IX (plasma derived - domestic) |
MonoFIX | 1000 IU | CSL Behring (Australia) Pty Ltd | $872.571 |
| Factor IX (recombinant - imported) |
BeneFIX | 250 IU | Pfizer Australia Pty Ltd | $197.50 |
| 500 IU | $395.00 | |||
| 1000 IU | $790.00 | |||
| 2000 IU | $1,580.00 | |||
| 3000 IU | $2,370.00 | |||
| Factor VIII (recombinant - imported) |
Adynovate | 250 IU | Shire Australia Pty Limited | * |
| 500 IU | * | |||
| 1000 IU | * | |||
| 2000 IU | * | |||
| Factor IX (recombinant - imported) |
Rixubis | 250 IU | Shire Australia Pty Limited |
$196.50 |
| 500 IU | $393.00 | |||
| 1000 IU | $786.00 | |||
| 2000 IU | $1,572.00 | |||
| 3000 IU | $2,358.00 | |||
| Factor XI (plasma derived - imported) |
Factor XI | 1 IU | CSL Behring (Australia) Pty Ltd | $12.60 |
| Factor XIII (plasma derived - imported) |
Fibrogammin | 250 IU | CSL Behring (Australia) Pty Ltd | $195.08 |
| 1250 IU | $975.38 | |||
| Factor XIII (recombinant - imported) |
NovoThirteen | 2500IU | Novo Nordisk Pharmaceuticals Pty Ltd | $30,000 |
| Human prothrombin complex (plasma derived - domestic) |
Prothrombinex | 500 IU | CSL Behring (Australia) Pty Ltd | $278.141 |
| Fibrinogen Concentrate (plasma derived – imported) | RiaSTAP | 1g | CSL Behring (Australia) Pty Ltd | $785.83 |
| Human C1 esterase inhibitor concentrate (plasma derived – imported) | Berinert | 500 IU | CSL Behring (Australia) Pty Ltd | $924.20 |
| Protein C concentrate (plasma derived - imported) | Ceprotin | 500 IU | Shire Australia Pty Limited |
$1,075.00 |
| 1000 IU | $2,150.00 | |||
| Antithrombin III concentrate (plasma derived - domestic) | Thrombotrol VF | 1000 IU | CSL Behring (Australia) Pty Ltd | $1,407.021 |
| Intravenous IVIg (plasma derived – domestic) |
Intragam P | 3g/50ml | CSL Behring (Australia) Pty Ltd | $175.481 |
| Intravenous IVIg (plasma derived – domestic) | Intragam 10 | 2.5g/25ml | CSL Behring (Australia) Pty Ltd | $146.231 |
| 10g/100ml | $584.931 | |||
| 20g/200ml | $1,169.861 | |||
| SCIg (plasma derived – domestic) | Evogam | 16% 0.8g/5ml | CSL Behring (Australia) Pty Ltd | $46.791 |
| 15% 3.2g/20ml | $187.181 | |||
| IVIg (plasma derived - imported) | Flebogamma DIF | 5% 0.5g/10ml | Grifols Australia Pty Ltd | $22.50 |
| 5% 2.5g/50ml | $112.50 | |||
| 5% 5g/100ml | $225.00 | |||
| 5% 10g/200ml | $450.00 | |||
| 5% 20g/400ml | $900.00 | |||
| 10% 5g/50ml | $225.00 | |||
| 10% 10g/100ml | $450.00 | |||
| 10% 20g/200ml | $900.00 | |||
| IVIg (plasma derived - imported) | Privigen | 5g/50ml | CSL Behring (Australia) Pty Ltd | $225.00 |
| 10g/100ml | $450.00 | |||
| 20g/200ml | $900.00 | |||
| 40g/400ml | $1,800.00 | |||
| SCIg (plasma derived - imported) | Hizentra | 1g/5ml | CSL Behring (Australia) Pty Ltd | $59.15 |
| 2g/10ml | $118.31 | |||
| 4g/20ml | $236.61 | |||
| 10g 50ml | $591.53 | |||
| Normal Ig NIg (plasma derived - domestic) |
Normal Ig VF | 2ml (0.32gm) | CSL Behring (Australia) Pty Ltd | $31.651 |
| 5ml (0.80gm) | $51.891 | |||
| CMV Ig (plasma derived - domestic) |
CMV Ig | 1.5 million units | CSL Behring (Australia) Pty Ltd | $1,203.131 |
| Hepatitis B Ig (plasma derived - domestic) |
Hepatitis B Ig | 100 IU (2ml) | CSL Behring (Australia) Pty Ltd | $43.981 |
| 400 IU (5ml) | $100.691 | |||
| Rh (D) Ig (plasma derived - imported) |
Rhophylac | 1500 IU | CSL Behring (Australia) Pty Ltd | $403.16 |
| Rh (D) Ig - VF (plasma derived - domestic) |
Rh (D) Ig | 250 IU | CSL Behring (Australia) Pty Ltd | $29.791 |
| 625 IU | $74.441 | |||
| Tetanus Ig (plasma derived - domestic) |
Tetanus Ig VF | 250 IU | CSL Behring (Australia) Pty Ltd | $43.471 |
| 4000 IU | $695.481 | |||
| Zoster Ig (plasma derived - domestic) |
Zoster Ig VF | 200 IU | CSL Behring (Australia) Pty Ltd | $272.751 |
* Extended half-life products supplied under limited and interim arrangements with no additional cost to the NBA budget.
1 The price does not include the starting plasma provided to CSL Behring (Australia) Pty Ltd by the Australian Red Cross Blood Service.